Gennex Laboratories Ltd

Statement of profit and loss

Parakho has not ingested a filed result for this company on a consolidated basis. When the company files one with the exchange, it appears here automatically.

Earnings call

Gennex Laboratories Ltd has not filed a concall transcript in the last 4 quarters.

Filings

12 shown · 27 published by the exchange

17 Aug 2026
Filing
Newspaper Publication
14 Aug 2026
Results
Un-Audited Financial Results For The Quarter Ended June 30, 2026
14 Aug 2026
Board meeting
Board Meeting Outcome for Un-Audited Financial Results For The Quarter Ended June 30, 2026
30 Jul 2026
Filing
Newspaper Publication
29 Jul 2026
Board meeting
Board Meeting Intimation for Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30, 2026.
17 Jul 2026
Filing
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
23 Jun 2026
Insider trading
Closure of Trading Window
10 Jun 2026
Insider trading
Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.
Appears 2 times in the recent filings shown; listed once.
10 Jun 2026
Insider trading
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
Appears 2 times in the recent filings shown; listed once.
01 Jun 2026
Filing
Newspaper Publication
30 May 2026
Results
Financial Result For The Quarter And Year Ended March 31, 2026
30 May 2026
Board meeting
Board Meeting Outcome for Meeting Held On Today I.E. 30Th May 2026

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Page generated from filings held to 17 Aug 2026.